Concepedia

Author

Craig Comisar

AstraZeneca (United Kingdom)

Also Known As

C. Comisar, Craig Comisar, Craig M. Comisar

15

Publications

371

Citations

5

H-Index

0

Concepts

All Affiliations

AstraZeneca (United Kingdom)Quantitative BioSciencesAstraZeneca (United States)
CC

About

Craig Comisar is an author at AstraZeneca (United Kingdom).

Craig Comisar

×

4

Publications

358

Citations

4

H-Index

YearCitations

Population pharmacokinetics and exposure‐response of osimertinib in patients with non‐small cell lung cancer

Kathryn H. Brown, Craig Comisar, Han Witjes,

British Journal of Clinical Pharmacology

2016

141

Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups

Jianguo Li, Mark Lovern, Michelle Green,

Clinical and Translational Science

2018

99

Pharmacokinetics, pharmacodynamics and safety of a human anti‐IL‐6 monoclonal antibody (sirukumab) in healthy subjects in a first‐in‐human study

Zhenhua Xu, Esther Bouman‐Thio, Craig Comisar,

British Journal of Clinical Pharmacology

2011

96

Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects

Yanli Zhuang, Zhenhua Xu, Dick E. de Vries,

International Journal of Clinical Pharmacology and Therapeutics

2013

22

Page 1